Human Papillomavirus (HPV) 16 and 18 Genotype by PCR, SurePath Human Immunodeficiency Virus 1 (HIV-1) by Quantitative PCR with Reflex to HIV PhenoSense GT Human Papillomavirus (HPV) Genotypes 16 and 18/45 by Transcription-Mediated Amplification (TMA), ThinPrep Human Immunodeficiency Virus 1 (HIV-1) by Quantitative PCR with Reflex to HIV-1 Genotype by Sequencing Homocysteine, Total Human Immunodeficiency Virus 1 by Quantitative PCR Homocystine Quantitative, Urine Human Immunodeficiency Virus 1, Genotype by Sequencing Homovanillic Acid (HVA), Urine Human Immunodeficiency Virus Type 1 (HIV-1) Antibody by CIA with Reflex to HIV-1 Antibody Confirmation by Western Blot HRAS Mutation Detection by Pyrosequencing Human Immunodeficiency Virus Type 1 (HIV-1) Antibody Confirmation by Western Blot Human Anti-Mouse Antibody (HAMA), ELISA Human Immunodeficiency Virus Type 1 (HIV-1) Antibody, Confirmation by Western Blot, with Reflex to HIV-2 Antibody Human Chorionic Gonadotropin (Beta-hCG) by Immunohistochemistry Human Immunodeficiency Virus Type 1 (HIV-1) Drug Resistance (GenoSURE PRIme) (Testing experiencing extended turnaround times at Monogram Biosciences.) Human Papillomavirus (HPV), High Risk by Transcription-Mediated Amplification (TMA), ThinPrep Hyper IgM Syndrome Panel, Sequencing (12 Genes) and Deletion/Duplication (10 Genes) Human Papillomavirus (HPV), High Risk with 16 and 18 Genotype by PCR, SurePath Hypersensitivity Pneumonitis Extended Panel (Farmer’s Lung Panel)
